Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure.

Afdhal, N., Giannini, E., Tayyab, G., Mohsin, A., Lee, J., Andriulli, A., Jeffers, L., Mchutchison, J., Chen, P., Han, K., Campbell, F., Hyde, D., Brainsky, A., Theodore, D., Grieco, A., Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia, <<NEW ENGLAND JOURNAL OF MEDICINE>>, 2012; 367 (8): 716-724. [doi:10.1056/NEJMoa1110709] [http://hdl.handle.net/10807/33915]

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

Grieco, Antonio
2012

Abstract

Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure.
2012
Inglese
Afdhal, N., Giannini, E., Tayyab, G., Mohsin, A., Lee, J., Andriulli, A., Jeffers, L., Mchutchison, J., Chen, P., Han, K., Campbell, F., Hyde, D., Brainsky, A., Theodore, D., Grieco, A., Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia, <<NEW ENGLAND JOURNAL OF MEDICINE>>, 2012; 367 (8): 716-724. [doi:10.1056/NEJMoa1110709] [http://hdl.handle.net/10807/33915]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/33915
Citazioni
  • ???jsp.display-item.citation.pmc??? 80
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 222
social impact